Director of Resmed board resigns
Tuesday, 10 June, 2008
A director of the Resmed (ASX: RMD) board has resigned, reducing the number of board members to eight.
Donagh McCarthy, president of the renal division of Baxter Healthcare in the US, has declined to stand for re-election to the board.
The remaining board members decided that instead of finding a replacement for McCarthy, the board would be reduced to eight.
Resmed founder Dr Peter Farrell will continue to hold the post of executive director of the board.
Farrell had previously arranged to become non-executive chairman by June 30.
Overuse of inhalers can increase heart attack risk
Overuse of reliever inhalers is associated with higher risks of developing and dying from...
Unhealthy Western diet could accelerate cognitive decline
An unhealthy Western-style diet is associated with a faster cognitive decline in people with a...
Cancer drug enters clinical trials based on a false mechanism
A cancer drug currently being tested in patients appears to have entered clinical trials based on...
